Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Melatonin on Bone Metabolism in Thalassemia Patients with Low Bone Mineral Density
TCTR20201223008Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in Thalassaemia, low bone mineral density, sponsored by Faculty of Medicine, Chiang Mai University. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
Thalassaemialow bone mineral density
Beyond the preview
Go deeper on TCTR20201223008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201223008.